thalidomide has been researched along with Herpes Simplex Virus Infection in 8 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a case of coinfection with disseminated HSV and VZV infection in a patient taking thalidomide for relapsed multiple myeloma." | 7.71 | Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. ( Curley, MJ; Hassoun, PM; Hussein, SA, 2002) |
| " We present a case of coinfection with disseminated HSV and VZV infection in a patient taking thalidomide for relapsed multiple myeloma." | 3.71 | Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. ( Curley, MJ; Hassoun, PM; Hussein, SA, 2002) |
| " Thalidomide (Synovir), developed by Celgene, has received limited approval for the treatment of leprosy." | 3.70 | FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration. ( Highleyman, L, 1998) |
| "Recognition and timely adequate treatment of erythema multiforme remain a major challenge." | 2.58 | Current Perspectives on Erythema Multiforme. ( Harr, T; Lerch, M; Mainetti, C; Terziroli Beretta-Piccoli, B, 2018) |
| "In thalidomide-treated mice, TNF-alpha RNA levels were reduced in the SCN." | 1.33 | Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-infected BALB/c mice. ( Atherton, SS; Fields, M; Zhang, M; Zheng, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerch, M | 1 |
| Mainetti, C | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Harr, T | 1 |
| König, C | 1 |
| Kleber, M | 1 |
| Reinhardt, H | 1 |
| Knop, S | 1 |
| Wäsch, R | 1 |
| Engelhardt, M | 1 |
| Aslam, A | 1 |
| Chalmers, R | 1 |
| Sohn, S | 2 |
| Lee, ES | 2 |
| Lee, SI | 1 |
| Kim, YA | 2 |
| Kwon, HJ | 2 |
| Bang, D | 2 |
| Lee, S | 2 |
| Fields, M | 1 |
| Zheng, M | 1 |
| Zhang, M | 1 |
| Atherton, SS | 1 |
| Highleyman, L | 1 |
| Curley, MJ | 1 |
| Hussein, SA | 1 |
| Hassoun, PM | 1 |
1 review available for thalidomide and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Current Perspectives on Erythema Multiforme.
Topics: Acyclovir; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythema Multiforme; Herpes Sim | 2018 |
7 other studies available for thalidomide and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
Topics: Acyclovir; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibiotic Prophylaxis; Antiviral Agent | 2014 |
Mucocutaneous ulceration in a previously healthy man.
Topics: Adult; Behcet Syndrome; Crohn Disease; Diagnosis, Differential; Erythema Multiforme; Herpes Simplex; | 2014 |
Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behçet's disease-like animal model.
Topics: Animals; Behcet Syndrome; Chemokine CCL4; Chemokines; Cytokines; Disease Models, Animal; Gene Expres | 2003 |
Thalidomide upregulates macrophage inflammatory protein-1alpha in a herpes simplex virus-induced Behçet's disease-like animal model.
Topics: Animals; Apoptosis; Behcet Syndrome; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Disease Models | 2004 |
Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-infected BALB/c mice.
Topics: Animals; Brain; Clodronic Acid; Female; Flow Cytometry; Fluorescent Antibody Technique; Herpes Simpl | 2006 |
FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; D | 1998 |
Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma.
Topics: Angiogenesis Inhibitors; Female; Herpes Simplex; Herpes Zoster; Humans; Middle Aged; Multiple Myelom | 2002 |